Forms of tiotropium bromide and processes for preparation thereof
WO2012061469A2
Crystalline forms of pralatrexate
CN102171233A
Process for preparing azacytidine intermediate
EP2142507A1
Process for the preparation of sorafenib and salts thereof
EP2231612A1
Polymorph form iii of sorafenib tosylate, sorafenib tosylate methanol solvate and sorafenib tosylate ethanol solvate, and processes for preparation thereof
WO2009086464A1
Process for preparing n-methyl-3, 4 dimethoxyphenylethylamine
WO2008150481A2
Processes for the preparation of crystalline form beta of imatinib mesylate
EP2253641A2
A process for preparing drospirenone and intermediate thereof
US2009264438A1
Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
EP2009008A1
Imatinib base, and imatinib mesylate and processes for preparation thereof
WO2008057291A2
Crystalline and amorphous imatinib base, imatinib mesylate- and processes for preparation thereof
EP2103612A1
Crystalline forms of palonosetron hydrochloride
EP2066682A2
Crystalline forms of valrubicin and processes for their preparation
WO2008021411A2
Processes for the preparation of lyophilized pharmaceutically acceptable salts of pemetrexed diacid
KR20090053812A
Processes for preparing intermediates of pemetrexed
EP1945645A1
Crystalline forms of pemetrexed diacid and processes for the preparation thereof
WO2008021410A2
Highly pure pemetrexed diacid and processes for the preparation thereof
MX2009000760A
Process for the preparation of solid sterile active pharmaceutical ingredient.
CN101522223A
Process for the preparation of solid sterile active pharmaceutical ingredient
KR20090038426A
Apparatus for the separation of a resin from a reaction mixture
